Literature DB >> 18572219

The incorporation of APOBEC3 proteins into murine leukemia viruses.

Li Zhang1, Xiaoyu Li, Jing Ma, Liyan Yu, Jiandong Jiang, Shan Cen.   

Abstract

APOBEC3 proteins represent a group of potent intrinsic inhibitors of retroviral replication. Murine APOBEC3 (mA3) is able to inhibit HIV-1, whereas it is inactive against Moloney murine leukemia virus (MLV). In this work, we present evidence showing that mA3, compared to hA3G, is incorporated inefficiently into MLV, while the abilities of mA3 and hA3G to be packaged into HIV-1 are similar. The nucleocapsid (NC) domain of HIV-1 is capable of facilitating the interaction of mA3 with HIV-1 Gag, and thereby the incorporation of mA3 into HIV-1. Swapping studies of the NC domains in HIV-1 and MLV indicate that MLV NC domain is responsible for viral exclusion of mA3, due to its inability to facilitate the mA3/Gag interaction. The interaction between mA3 and HIV-1 Gag is mediated by the linker region between two zinc coordination motifs in mA3, similar to what has been found for the incorporation of hA3G into both HIV-1 and MLV. These results suggest that the interaction between NC domains and the linker regions might represent a common mechanism for viral incorporation of APOBEC3 proteins, and the inefficient incorporation of endogenous mA3 appears to be a strategy by which MLV escapes the inhibitory effect of mA3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572219     DOI: 10.1016/j.virol.2008.05.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.

Authors:  Tobias Paprotka; Narasimhan J Venkatachari; Chawaree Chaipan; Ryan Burdick; Krista A Delviks-Frankenberry; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate with the Viral Envelope as a Type I Integral Membrane Protein.

Authors:  Tyler Milston Renner; Kasandra Bélanger; Cindy Lam; María Carla Rosales Gerpe; Joanne Eileen McBane; Marc-André Langlois
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

3.  Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.

Authors:  Harriet C T Groom; Melvyn W Yap; Rui Pedro Galão; Stuart J D Neil; Kate N Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

4.  Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores.

Authors:  John P Donahue; Rebecca T Levinson; Jonathan H Sheehan; Lorraine Sutton; Harry E Taylor; Jens Meiler; Richard T D'Aquila; Chisu Song
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

5.  Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV.

Authors:  Kristin Stieler; Nicole Fischer
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

6.  Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene.

Authors:  Audrey Low; Chioma M Okeoma; Nika Lovsin; Marcelo de las Heras; Thomas H Taylor; B Matija Peterlin; Susan R Ross; Hung Fan
Journal:  Virology       Date:  2009-01-15       Impact factor: 3.616

7.  The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3.

Authors:  Marc-André Langlois; Kristin Kemmerich; Cristina Rada; Michael S Neuberger
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

8.  Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.

Authors:  Atsushi Koito; Terumasa Ikeda
Journal:  Front Microbiol       Date:  2013-02-20       Impact factor: 5.640

9.  Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.

Authors:  Mohammad A Khan; Ritu Goila-Gaur; Sandra Kao; Eri Miyagi; Robert C Walker; Klaus Strebel
Journal:  Retrovirology       Date:  2009-11-03       Impact factor: 4.602

10.  Are viruses inhibited by APOBEC3 molecules from their host species?

Authors:  Susan R Ross
Journal:  PLoS Pathog       Date:  2009-04-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.